IDiyas

For the Inventor, By the Inventor

Norcross, GA, United States of America

Galectin Therapeutics, Inc.


USPTO Granted Patents = 18



Trademarks = 3

Forward Citations = 73

Loading Chart...
Loading Chart...

7 inventors (with patents filed for the assignee):

goldMedal Eliezer Zomer (16 out of 38 patents)

silverMedal Anatole A Klyosov (15 out of 28 patents)

bronzeMedal Peter G Traber (13 out of 17 patents)

4.  Elena Chekhova (7 out of 7 patents)

5.  David C Platt (5 out of 64 patents)

6.  William L Redmond (1 out of 2 patents)

7.  Stefanie N Linch (1 out of 2 patents)


18 patents:

1. 11413303 - Methods for treatment of arthritis (2022-08-16),
2. 10799525 - Composition of novel carbohydrate drug for treatment of human diseases (2020-10-13),
3. 10744154 - Galactose-pronged polysaccharides in a formulation for antifibrotic therapies (2020-08-18),
4. 10420793 - Composition of novel carbohydrate drug for treatment of human diseases (2019-09-24),
5. 10398778 - Method for enhancing specific immunotherapies in cancer treatment (2019-09-03),
6. 9974802 - Composition of novel carbohydrate drug for treatment of human diseases (2018-05-22),
7. 9968631 - Method for treatment of pulmonary fibrosis (2018-05-15),
8. 9763974 - Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase (2017-09-19),
9. 9649327 - Composition of novel carbohydrate drug for treatment of human diseases (2017-05-16),
10. 9339515 - Method for treatment of pulmonary fibrosis (2016-05-17),
11. 9200090 - Galactose-pronged polysaccharides in a formulation for antifibrotic therapies (2015-12-01),
12. 8962824 - Composition of novel carbohydrate drug for treatment of human diseases (2015-02-24),
13. 8871925 - Compositions of novel carbohydrate drug for treatment of human diseases (2014-10-28),
14. 8828971 - Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders (2014-09-09),
15. 8722645 - Galactose-pronged polysaccharides in a formulation for antifibrotic therapies (2014-05-13),
Galectin Therapeutics, Inc. is a biotechnology company focused on the development of novel therapies for fibrotic diseases and cancer. They are dedicated to leveraging their expertise in galectin proteins to create treatments that address unmet medical needs. With a focus on galectin inhibitors, their research and development efforts aim to provide effective therapies for patients suffering from various diseases that involve galectin dysregulation.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

18 Patents

#34 in Norcross, GA

#347 in Georgia

#17,372 in US

#33,129 in the World

...
Norcross, GA, United States of America

Galectin Therapeutics, Inc.

Forward Citations = 73

7 inventors:

goldMedal Eliezer Zomer (16 out of 38 patents)

silverMedal Anatole A Klyosov (15 out of 28 patents)

bronzeMedal Peter G Traber (13 out of 17 patents)

4.  Elena Chekhova (7 out of 7 patents)

5.  David C Platt (5 out of 64 patents)

Please report any incorrect information to support@idiyas.com
Loading…